SECONDARY PREVENTION IN PATIENTS AFTER MYOCARDIAL INFARCTION AT AMBULATORY SPECIALIZED CARDIOLOGY INSTITUTION (PHARMACOEPIDEMIOLOGY STUDY)

SECONDARY PREVENTION IN PATIENTS AFTER MYOCARDIAL INFARCTION AT AMBULATORY SPECIALIZED CARDIOLOGY INSTITUTION (PHARMACOEPIDEMIOLOGY STUDY)

Aim. To assess 5 years trend in level of doctor’s adherence to actual guidelines on secondary prevention of cardiovascular diseases in patients with a history of myocardial infarction in ambulatory specialized healthcare institution in Moscow. Material and methods. There were 752 patients firstly vi...

Full description

Saved in:

Bibliographic Details
Main Authors:	S. B. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, D. A. Dimitrova
Format:	Article
Language:	English
Published:	Столичная издательская компания 2017-05-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	secondary prevention antiplatelets statins ace inhibitors beta-blockers pharmacoepidemiology
Online Access:	https://www.rpcardio.online/jour/article/view/1441
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY)
by: S. В. Fitilev, et al.
Published: (2018-05-01)

EFFECT OF CARDIOVASCULAR DRUGS ON BONE HEALTH AND THE POSSIBILITY OF THEIR USE FOR THE PREVENTION OF OSTEOPOROSIS
by: I. A. Skripnikova, et al.
Published: (2015-12-01)

TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN REAL CLINICAL PRACTICE ACCORDING TO THE DATA FROM PROGNOZ IBS REGISTER (PART 2)
by: S. N. Tolpygina, et al.
Published: (2015-09-01)

SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES AMONG PATIENTS OF DIFFERENT AGE GROUPS WITH A HISTORY OF MYOCARDIAL INFARCTION BY THE EXAMPLE OF OUTPATIENT CARDIOLOGY INSTITUTION
by: S. B. Fitilev, et al.
Published: (2017-07-01)

PHARMACOEPIDEMIOLOGY AND THE EFFICACY OF ANTIHYPERTENSIVE TREATMENT IN REAL-LIFE PRACTICE OF THE CARDIOLOGY REFERRAL CLINIC
by: A. V. Kontsevaya, et al.
Published: (2015-09-01)

Lipid-lowering therapy in patients with coronary artery disease in primary care practices: what has changed over 7 years?
by: S. K. Zyryanov, et al.
Published: (2020-09-01)

PHARMACOEPIDEMIOLOGIC ANALYSIS OF HOSPITAL TREATMENT OF PATIENTS WITH CEREBRAL INFARCTION AND ATRIAL FIBRILLATION
by: N. V. Mikheeva, et al.
Published: (2015-09-01)

MODERN POTENTIAL OF MYOCARDIAL INFARCTION TREATMENT IN THE POLYCLINIC SETTINGS (LECTURE)
by: Yu. I. Nesterov
Published: (2013-06-01)

MYOCARDIAL FIBROSIS IN PATIENTS WITH DIABETES MELLITUS
by: O. M. Drapkina, et al.
Published: (2015-09-01)

Beta blocker use and breast cancer survival by subtypes: A population-based cohort study
by: Oliver William Scott, et al.
Published: (2025-06-01)

Insufficient use of statins in the primary and secondary prevention of myocardial infarction: an urgent problem in modern cardiology
by: N. G. Lozhkina, et al.
Published: (2025-04-01)

Review: Investigation of the electrochemical properties of beta blockers and ACE inhibitors by cyclic voltammetry
by: Edhem Hasković, et al.
Published: (2020-06-01)

PHARMACOEPIDEMIOLOGIC ANALYSIS OF ST-ELEVATION MYOCARDIAL INFARCTION REPERFUSION THERAPY AT SARATOV REGION HOSPITALS OF DIFFERENT TYPES
by: O. V. Reshetko, et al.
Published: (2016-01-01)

RESULTS OF PHARMACOEPIDEMIOLOGIC STUDY OF ARTERIAL HYPERTENSION PIFAGOR IV: PHYSICIANS COMPLIANCE
by: M. V. Leonova, et al.
Published: (2015-01-01)

ROLE OF RANDOMIZED TRIALS IN PHARMACOEPIDEMIOLOGY
by: T. L. Galankin, et al.
Published: (2015-03-01)

Pharmacoepidemiology of stroke treatment in different hospitals
by: N. V. Mikheeva, et al.
Published: (2015-03-01)

PHARMACOEPIDEMIOLOGY IN THE ASSORTMENT POLICY-PRODUCER OF DRUGS
by: V. Y. Krasnov
Published: (2015-09-01)

Pharmacoepidemiological Study of the Use of Antibacterial Agents in the Multi-Speciality Hospitals of St. Petersburg
by: S. V. Sidorenko, et al.
Published: (2020-05-01)

Pediatric heart failure: Current approach and treatment
by: Benjamin A. Olsen, et al.
Published: (2025-08-01)

PHARMACOEPIDEMIOLOGY: FROM THEORY TO PRACTICE
by: S. A. Rachina, et al.
Published: (2015-03-01)

COMPARATIVE PHARMACOEPIDEMIOLOGICAL ASSESSMENT OF ANTIHYPERTENSIVE DRUGS PRESCRIPTION IN OUTPATIENT PRACTICE IN KURSK AND CHISINAU
by: S. V. Povetkin, et al.
Published: (2018-07-01)

Adherence to pharmacotherapy for secondary prevention of coronary heart disease: A registry-based prospective study
by: Aradhai Bana, et al.
Published: (2025-03-01)

PHARMACOEPIDEMIOLOGICAL AND PHARMACOECONOMIC STUDIES OF ANTIHYPERTENSIVE TREATMENT IN RUSSIA. Analytical Review
by: T. S. Romanenko, et al.
Published: (2015-09-01)

PHARMACOEPIDEMIOLOGY OF PHYSICIANS’ INDICATIONS IN PATIENTS WITH POSTINFARCTIONCARDIOSCLEROSIS
by: O. N. Kurochkinа, et al.
Published: (2015-03-01)

THE ROLE OF CARVEDILOL IN THE PREVENTION OF CARDIOMYOCYTE APOPTOSIS CAUSED BY ACUTE MYOCARDIAL INFARCTION
by: A. N. Zakirova, et al.
Published: (2017-12-01)

Guideline-Directed Medical Therapy in the Management of Cardiovascular Disease: A Cross-sectional Questionnaire-based Study amongst Indian Healthcare Professionals
by: Prafulla Kerkar, et al.
Published: (2025-04-01)

Pharmacological Treatment of Ascites: Challenges and Controversies
by: Jimmy Che-To Lai, et al.
Published: (2025-02-01)

METOPROLOL AND CARVEDILOL IN THERAPY OF ACUTE MYOCARDIAL INFARCTION: WHEN AND WHICH DRUG TO PREFER
by: B. N. Garifullin, et al.
Published: (2016-01-01)

Systematic review of Mendelian randomization studies on antihypertensive drugs
by: Bohan Fan, et al.
Published: (2024-11-01)

Drug utilization research at the individual level as the main concept of pharmacoepidemiology
by: S. M. Mukhina, et al.
Published: (2023-08-01)

PHARMACOEPIDEMIOLOGICAL STUDY OF DOCTORS HABITS IN PRESCRIPTIONS OF ANTIHYPERTENSIVE DRUGS IN TOWN OF OREL
by: G. I. Shvets, et al.
Published: (2016-01-01)

Conservative treatment for acute coronary syndrome in patients with type 2 diabetes mellitus
by: Sergey Valentinovich Kakorin, et al.
Published: (2013-06-01)

Continuation vs Withdrawal of Beta-Blockers and Outcomes After Myocardial Infarction With Preserved Left Ventricular Function
by: Michael H. Chiu, MD, MSc, et al.
Published: (2025-06-01)

PHARMACOEPIDEMIOLOGY OF ORIGINAL DROTAVERINE USE IN DYSMENORRHEA: RESULTS OF AN INTERNATIONAL MULTICENTER STUDY
by: A. L. Unanyan, et al.
Published: (2015-03-01)

Pharmacoepidemiology of antidepressants in the Russian Federation
by: Yu. M. Gomon, et al.
Published: (2025-04-01)

AN ISSUE OF DRUG INTERACTION IN CARDIOLOGICAL PRACTICE: WHAT SHALL PHYSICIAN BE AWARE OF?
by: E. I. Tarlovskaya, et al.
Published: (2015-12-01)

Drug therapy for obesity in the Russian Federation: pharmacoepidemiological study
by: V. V. Strizheletsky, et al.
Published: (2022-10-01)

Changes in Antithrombotic Therapy of Atrial Fibrillation in the Hospital in 2011-2012 and 2016-2017 (Pharmacoepidemiological Analysis)
by: O. V. Reshetko, et al.
Published: (2020-11-01)

Assessing the implementation of the recommendations on secondary cardiovascular prevention in patients after myocardial infarction (a pharmaco-epidemiologic study)
by: R. G. Oganov, et al.
Published: (2009-08-01)

ANALYSIS OF ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT ATRIAL FIBRILLATION (PHARMACOEPIDEMIOLOGY STUDY)
by: V. I. Petrov, et al.
Published: (2015-09-01)